12.40p+0.63 (+5.31%)22 Jul 2025, 16:34
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Futura Medical PLC Fundamentals

Company NameFutura Medical PLCLast Updated2025-07-22
IndustryBiotechnologySectorHealthcare
Shares in Issue303.830 mMarket Cap£37.67 m
PE Ratio28.72Dividend per Share0
Dividend Yield0Dividend Cover0
EPS£0.00EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ratio1.5163Cash Equity Ratio0.7360
Quick Ratio2.0459Current Ratio2.47
Price To Book Value3.9920ROCE0

Futura Medical PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Futura Medical PLC Company Financials

Assets202420232022
Tangible Assets£4.09 m£2.48 m£1.16 m
Intangible Assets000
Investments000
Total Fixed Assets£4.09 m£2.48 m£1.16 m
Stocks£455,906.00£339.000
Debtors£1.27 m£1.15 m£70,114.00
Cash & Equivalents£6.60 m£7.71 m£4.03 m
Other Assets000
Total Assets£13.59 m£11.82 m£6.47 m
Liabilities202420232022
Creditors within 1 year£3.84 m£6.34 m£1.75 m
Creditors after 1 year£782,587.0000
Other Liabilities000
Total Liabilities£4.63 m£6.34 m£1.75 m
Net assets£8.96 m£5.48 m£4.72 m
Equity202420232022
Called up share capital£607,407.00£602,812.00£576,093.00
Share Premium£71.24 m£71.07 m£66.55 m
Profit / Loss£1.29 m-£6.89 m-£6.87 m
Other Equity£8.96 m£5.48 m£4.72 m
Preference & Minorities000
Total Capital Employed£8.96 m£5.48 m£4.72 m
Ratios202420232022
Debt Ratio000
Debt-to-Equity000
Assets / Equity1.51631.51631.5163
Cash / Equity0.73600.73600.7360
EPS£0.00-£0.02-£0.02
Cash Flow202420232022
Cash from operating activities£391,472.00£570,253.00-£5.78 m
Cashflow before financing£562,383.00£5.12 m-£5.61 m
Increase in Cash-£1.12 m£3.69 m-£6.35 m
Income202420232022
Turnover£13.93 m£3.10 m0
Cost of sales£4.24 m£1.33 m0
Gross Profit£9.69 m£1.77 m0
Operating Profit£1.24 m-£6.96 m-£6.87 m
Pre-Tax profit£1.29 m-£6.89 m-£6.87 m

Futura Medical PLC Company Background

SectorHealthcare
ActivitiesFutura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union.
Latest Interim Date10 Sep 2024
Latest Fiscal Year End Date15 Apr 2025

Futura Medical PLC Directors

AppointedNamePosition
2025-07-08Mr. Jeffrey Robert NeedhamNon-Executive Director,Chairman
2023-07-18Mr. John Milne ClarkeNon-Executive Director,Chairman
2016-03-31Ms. Lisa Arnold Non-Executive Director
2012-02-01Dr. William Duncan PotterExecutive Director,Chairman
2025-01-13Mr. Andrew Vaughan UnittNon-Executive Director,Senior Independent Director
2025-07-08Mr. James Henry BarderExecutive Director,Chief Executive
2021-12-29Mr. Jonathan David Freeman Non-Executive Director,Senior Independent Director
2015-03-28Mr. David Bryn DaviesExecutive Director,Chief Development Officer
2018-04-09Mr. Derek Adrian MartinExecutive Director,Finance Director and Company Secretary
2011-08-09Mr. Anthony Louis Clayden BSc,FCA,MSIExecutive Director,Finance Director and Company Secretary
2025-05-27Mr. Kenneth William JamesExecutive Director,Head of RandD
2025-05-27Ms. Angela HildrethExecutive Director,Finance Director, Chief Operating Officer and Company Secretary
2025-01-13Mr. Gordon Roy DavisNon-Executive Director

Futura Medical PLC Contact Details

Company NameFutura Medical PLC
Address40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG
Telephone+44 1483685670
Websitehttps://www.futuramedical.com

Futura Medical PLC Advisors

AuditorKPMG
Phone+44 1189642000
Fax+44 1189642222
BankHSBC Bank PLC
SolicitorWithers & Rogers LLP
Phone+44 2079403600
Fax+44 2073789680
StockbrokerN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
Nominated AdviserN+1 Singer
Phone+44 2074963000
Fax+44 2074963150
RegistrarCapita Asset Services
Phone+44 8716640300
Fax+44 2086392342
Financial PR AdviserBuchanan
Phone+44 2074665000
Fax+44 2074665001
SolicitorMemery Crystal
Phone+44 2072425905
Fax+44 2072422058